Benjamin Levy on Advances in Diagnosing Lung Cancer

Article

Benjamin Levy, MD, medical director, Thoracic Oncology, Mount Sinai Health System, discusses recent advances in the detection and diagnosis of lung cancer.

Benjamin Levy, MD, medical director, Thoracic Oncology, Mount Sinai Health System, discusses recent advances in the detection and diagnosis of lung cancer.

Lung cancer has traditionally been diagnosed using tissue biopsies, though over the past two years, Levy says research shows diagnoses can be achieved early through a simple blood test. These blood samples contain cell-free DNA (cfDNA) that is shed from the tumor and may provide useful biomarkers or molecular drivers.

Similar to tissue biopsies, molecular profiling can also be performed on blood samples, Levy adds.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.